Riskpilot← Back to searchSign inGet full accessMoreld AB
ABActiveOrg 5593381394Kastellgatan 4 AGeneral medical practice activities · NACE 8621Est. 20210 employees
Revenue 2024
SEK 2,1M
-4% vs 2023
EBITDA margin
27.1%
-3% vs 2023
Equity ratio
97.0%
Financial strength
Net profit 2024
SEK 402K
-15% vs 2023
| Revenue | SEK 2,1M | -4% |
| EBITDA | SEK 579K | -3% |
| Net profit | SEK 402K | -15% |
| Total assets | SEK 1,7M | -15% |
| Equity | SEK 1,6M | +14% |
| Employees | 0 | — |
Legal name
Moreld AB
Org number
5593381394
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
1 oktober 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva hälso- och sjukvård inom primär- och sluten vård och angränsade verksamhetsområden inklusive medicinska konsulttjänster och diagnostiska metoder. Aktiebolaget ska bedriva friskvård, bland annat med inriktning på reträtt och hälsoturism. Aktiebolaget ska sälja friskvårds- relaterade produkter exempelvis böcker, kurser, föreläsningar samt bedriva hälsoinriktad affärsutveckling. Aktiebolaget ska äga och förvalta värdepapper. Aktiebolaget ska äga och förvalta fastigheter relaterade till ovan nämnda kärnverksamheter.
Address
Kastellgatan 4 A
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 3 142 | 2 224 | 2 139 |
| Staff expenses | −1 353 | −1 303 | −979 |
| EBITDA | 1 373 | 594 | 579 |
| Depreciation & amort. | −3 | −17 | −42 |
| EBIT | 1 370 | 577 | 537 |
| Net financials | 1 | 16 | −24 |
| Profit before tax | 1 371 | 593 | 513 |
| Tax | −284 | −119 | −111 |
| Net profit | 1 087 | 474 | 402 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 1 612 | 1 951 | 1 654 |
| Equity | 1 112 | 1 406 | 1 604 |
| Long-term debt | — | — | — |
| Short-term debt | 501 | 545 | 50 |
| Total debt | 501 | 545 | 50 |
EBITDA margin
27.1%
This company
15.8%
Market median
+72% vs market
20222024
Equity ratio
97.0%
This company
38.2%
Market median
+154% vs market
20222024
Return on equity
25.1%
This company
18.4%
Market median
+36% vs market
20222024
Net profit margin
18.8%
This company
8.1%
Market median
+132% vs market
20222024
Asset turnover
1.29×
This company
1.12×
Market median
+15% vs market
20222024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20222024
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (4) | ||
| Board of Directors | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Moreld AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mohammed Abba Aji | Board of Directors | 0 companies |
| Lina Anna Elisabeth Nordström | Board of Directors | 0 companies |
| Emre Yercok | Deputy Board Member | 0 companies |
| Lars Hugo Viking Rillner | Deputy Board Member | 0 companies |
| Petra Maria Nilsson Andersson | Deputy Board Member | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |